• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

不同小鼠品系中的皮肤致癌作用及启动子结合特性

Skin carcinogenesis and promoter binding characteristics in different mouse strains.

作者信息

Wheldrake J F, Marshall J, Ramli J, Murray A W

出版信息

Carcinogenesis. 1982;3(7):805-7. doi: 10.1093/carcin/3.7.805.

DOI:10.1093/carcin/3.7.805
PMID:6811150
Abstract

The sensitivity of various mouse strains to skin carcinogenesis has been investigated in two ways; (i) by comparing carcinogenesis induced by treatments involving both the application of tumour promoters and the application of single or multiple doses of a carcinogen, and (ii) by comparing the binding characteristics of the tumour promoter [3H]phorbol-12,13-dibutyrate to particulate skin preparations. The mouse strains tested were Swiss albino, Balb/c, C3H, LACA and AKR/J. Although some differences were apparent, Swiss albino, LACA and C3H mice were generally sensitive to skin carcinogenesis by both benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene, either with or without promotion with croton oil. AKR/J mice were sensitive to both carcinogens with promotion but relatively insensitive in the absence of promotion. Balb/c mice had low sensitivity except when exposed to repeated low doses of benzo[a]pyrene. The [3H]phorbol-12,13-dibutyrate binding characteristics of particulate skin preparations from all strains were indistinguishable.

摘要

已通过两种方式研究了各种小鼠品系对皮肤致癌作用的敏感性

(i)通过比较涉及应用肿瘤促进剂以及单次或多次剂量致癌物的处理所诱导的致癌作用,以及(ii)通过比较肿瘤促进剂[3H]佛波醇-12,13-二丁酸酯与皮肤颗粒制剂的结合特性。所测试的小鼠品系为瑞士白化小鼠、Balb/c、C3H、LACA和AKR/J。尽管存在一些明显差异,但瑞士白化小鼠、LACA和C3H小鼠通常对苯并[a]芘和7,12-二甲基苯并[a]蒽诱导的皮肤致癌作用敏感,无论是否用巴豆油促进。AKR/J小鼠在有促进作用时对两种致癌物均敏感,但在无促进作用时相对不敏感。Balb/c小鼠敏感性较低,除非暴露于反复低剂量的苯并[a]芘。所有品系皮肤颗粒制剂的[3H]佛波醇-12,13-二丁酸酯结合特性无明显差异。

相似文献

1
Skin carcinogenesis and promoter binding characteristics in different mouse strains.不同小鼠品系中的皮肤致癌作用及启动子结合特性
Carcinogenesis. 1982;3(7):805-7. doi: 10.1093/carcin/3.7.805.
2
Skin carcinogenesis as a model system: observations on species, strain and tissue sensitivity to 7,12-dimethylbenz(a)anthracene with or without promotion from croton oil.作为模型系统的皮肤致癌作用:关于物种、品系和组织对7,12 - 二甲基苯并(a)蒽的敏感性观察,无论有无巴豆油促进作用。
Acta Pharmacol Toxicol (Copenh). 1980 Feb;46(2):89-97. doi: 10.1111/j.1600-0773.1980.tb02426.x.
3
Two-stage skin carcinogenesis in sensitive and resistant mouse strains.敏感和抗性小鼠品系中的两阶段皮肤致癌作用。
Carcinogenesis. 1982;3(1):99-102. doi: 10.1093/carcin/3.1.99.
4
Tephrosia purpurea alleviates phorbol ester-induced tumor promotion response in murine skin.紫穗槐可减轻佛波酯诱导的小鼠皮肤肿瘤促进反应。
Pharmacol Res. 2001 Feb;43(2):135-44. doi: 10.1006/phrs.2000.0711.
5
Effect of deoxycholic acid on 7,12-dimethylbenz(a)anthracene-induced, two-stage mouse skin carcinogenesis.脱氧胆酸对7,12-二甲基苯并(a)蒽诱导的两阶段小鼠皮肤致癌作用的影响。
Res Commun Chem Pathol Pharmacol. 1978 Dec;22(3):609-12.
6
Overview of tumor promotion in animals.动物肿瘤促进作用概述。
Environ Health Perspect. 1983 Apr;50:3-14. doi: 10.1289/ehp.83503.
7
Mouse skin melanoma induced in two stage chemical carcinogenesis with 7,12-dimethylbenz[a]anthracene and croton oil.用7,12-二甲基苯并[a]蒽和巴豆油通过两阶段化学致癌法诱导的小鼠皮肤黑色素瘤。
Carcinogenesis. 1985 Jun;6(6):921-3. doi: 10.1093/carcin/6.6.921.
8
NTP Comparative Initiation/Promotion Skin Paint Studies of B6C3F1 Mice, Swiss (CD-1(R)) Mice, and SENCAR Mice.NTP对B6C3F1小鼠、瑞士(CD-1(R))小鼠和SENCAR小鼠进行的比较启动/促进皮肤涂抹研究。
Natl Toxicol Program Tech Rep Ser. 1996 Feb;441:1-201.
9
Initiation-promotion skin carcinogenesis and immunological competence.启动-促癌皮肤致癌作用与免疫能力
Proc Soc Exp Biol Med. 1975 Oct;150(1):61-4. doi: 10.3181/00379727-150-38974.
10
Murine susceptibility to two-stage skin carcinogenesis is influenced by the agent used for promotion.小鼠对两阶段皮肤致癌作用的易感性受用于促癌的试剂影响。
Carcinogenesis. 1984 Mar;5(3):301-7. doi: 10.1093/carcin/5.3.301.